Fed. Circ. Affirms Dismissal Of AIDS Drug Antitrust Case
A Federal Circuit panel affirmed Friday a California district court's ruling that AIDS Healthcare Foundation Inc. can't invalidate five patents for HIV treatments or support antitrust claims against Gilead Sciences Inc....To view the full article, register now.
Already a subscriber? Click here to view full article